Description
Tirzepatide – 30mg
30mg per vial · lyophilized research peptide
What it is
Tirzepatide is a dual-agonist research peptide that acts on GIP and GLP-1 receptors. If Semaglutide is the classic GLP-1 research option, Tirzepatide is the dual-pathway upgrade most buyers compare next.
Why researchers look for it
Shoppers usually want a trusted 30mg vial, clear labeling, and bulk options. That is exactly how this listing is set up.
Common research interest
- Weight-management and metabolic research
- Dual incretin (GIP + GLP-1) pathway studies
- Appetite / energy-balance research models
- Labs that outgrew standard 10mg formats
Pairs well in catalogs next to Semaglutide (single pathway) and Retatrutide (triple pathway) for pathway-comparison research.
Quality & Handling
- Lyophilized (freeze-dried) powder
- Research grade
- Third-party tested
- COA available
- Clearly labeled Gigatides packaging
Store sealed, cool, and dry. Protect from heat, light, and moisture.
Important
For research use only. Not for human consumption. Not a drug. Not intended to diagnose, treat, cure, or prevent any disease.












Reviews
There are no reviews yet.